Pulmonary Emboli Imaging with 99mTc-labelled Anti-D-dimer (DI-80B3) Fab′ Followed by SPECT

Heart Lung and Circulation

Volumn 20, Issue 8, 2011, Pages 503-511

  Morris, Timothy A ^a   Gerometta, Michael ^b   Smart, Richard C ^c   Eisenberg, Paul ^d   Roach, Paul J ^e   Tsui, Wendy W ^c   Better, Nathan ^f   Taubman, Kim L ^g   Unger, Steven A ^h   Macfarlane, David ⁱ  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Agen Biomedical Ltd Australia   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

^d AMGEN INC   (United States)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g ST VINCENT S HOSPITAL   (Australia)

^h QUEEN ELIZABETH HOSPITAL   (Australia)

ⁱ ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Pulmonary embolism; Radioimmunoimaging; Single photon emission computerised tomography

Indexed keywords

HUMANISED ANTI FIBRIN D DIMER IMMUNOGLOBULIN F(AB) FRAGMENT TECHNETIUM TC 99M; TECHNETIUM 99M; THROMBOVIEW; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL STUDY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMMUNE RESPONSE; LUNG EMBOLISM; LUNG SCINTISCANNING; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PULMONARY EMBOLISM; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 79960649140     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2011.03.113     Document Type: Article

References (28)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-e146.
2. Silverstein M.D., Heit J.A., Mohr D.N., Petterson T.M., O'Fallon W.M., Melton L. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998, 158:585-593.
3. Rubinstein I., Murray D., Hoffstein V. Fatal pulmonary emboli in hospitalized patients. An autopsy study. Arch Intern Med 1988, 148:1425-1426.
4. Morgenthaler T.I., Ryu J.H. Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clin Proc 1995, 70:417-424.
5. Karwinski B., Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol 1989, 42:135-139.
6. Stein P.D., Henry J.W. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995, 108:978-981.
7. Douketis J.D., Kearon C., Bates S., Duku E.K., Ginsberg J.S. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998, 279:458-462.
8. Morris T.A., Marsh J.J., Chiles P.G., Konopka R.G., Pedersen C.A., Schmidt P.F., et al. Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer. Am J Respir Crit Care Med 2004, 169:987-993.
9. Morris T.A., MacFarlane D.J., Eisenberg P.R., Smart R.C., Gerometta M. Clinical diagnostic imaging of pulmonary emboli using radiolableled anti-crosslinked fibrin antibodies (thromboview). Chest 2006, 130:275S-276S.
10. Rylatt D.B., Blake A.S., Cottis L.E., Massingham D.A., Fletcher W.A., Masci P.P., et al. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983, 31:767-778. JID 326377.
11. Lamoyi E., Nisonoff A. Preparation of F(ab′)2 fragments from mouse IgG of various subclasses. J Immunol Methods JID -1305440 1983, 56:235-243.
12. 99mTc-DI-DD-3B6/22-80B3 Fab'. Eur J Nucl Med Mol Imaging 2006, 33:648-656.
13. Carlson M.K., Gleason P.P., Sen S. Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity. Pharmacotherapy 2001, 21:108-113.
14. Fiessinger J.N., Huisman M.V., Davidson B.L., Bounameaux H., Francis C.W., Eriksson H., et al. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA 2005, 293:681-689.
15. Macfarlane D., Socrates A., Eisenberg P., Larcos G., Roach P., Gerometta M., et al. Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab' fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial. Eur J Nucl Med Mol Imaging 2009, 36:250-259.
16. FDA: Prescribing label for LOVENOX (enoxaparin) NDA 020164 approved 12/23/2009. In: Book prescribing label for LOVENOX (enoxaparin) NDA 020164 approved 12/23/2009. City; 2009.
17. Lusiani L., Zanco P., Visona A., Breggion G., Pagnan A., Ferlin G. Immunoscintigraphic detection of venous thrombosis of the lower extremities by means of human anitfibrin monoclonal antibodies labeled with In-111. Angiology 1989, 40:671-677.
18. Jung M., Kletter K., Dudczak R., Koppensteiner R., Minar E., Kahls P., et al. Deep vein thrombosis: scintigraphic diagnosis with In-111-labeled monoclonal antifibrin antibodies. Radiology 1989, 173:469-475.
19. Alavi A., Palevsky H.I., Gupta N., Meranze S., Kelly M.A., Jatlow A.D., et al. Radiolabeled antifibrin antibody in the detection of venous thrombosis: preliminary results. Radiology 1990, 175:79-85.
20. Morris T.A., Marsh J.J., Fagnani R., Hagan M., Moser K.M. Degree of polymer organization decreases the binding of a monoclonal antibody raised against the beta-chain amino terminus of fibrin. Thromb Haemostasis 1997, 77:704-709.
21. Hyers T.M., Agnelli G., Hull R.D., Morris T.A., Samama M., Tapson V.F., et al. Antithrombotic therapy for venous thromboembolic disease. Chest JID-0231335 2001, 119:176S-193S.
22. Morris T.A., Marsh J.J., Konopka R., Pedersen C.A., Chiles P.G., Fagnani R., et al. Antibodies against the fibrin beta-chain amino-terminus detect active canine venous thrombi. Circulation 1997, 96:3173-3179.
23. Morris T.A., Marsh J.J., Konopka R., Pedersen C.A., Chiles P.G. Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism. Thromb Res JID-0326377 2000, 100:185-194.
24. Stein P.D., Fowler S.E., Goodman L.R., Gottschalk A., Hales C.A., Hull R.D., et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006, 354:2317-2327.
25. James W.S., Menn S.J., Moser K.M. Rapid resolution of a pulmonary embolus in man. West J Med 1978, 128:60-64.
26. Dalen J.E., Banas J.S., Brooks H.L., Evans G.L., Paraskos J.A., Dexter L. Resolution rate of acute pulmonary embolism in man. N Engl J Med 1969, 280(22):1194-1199.
27. Tow D.E., Wagner H.N. Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med 1967, 276:1053-1059.
28. Morris T.A., Marsh J.J., Chiles P.G., Pedersen C.A., Konopka R.G., Gamst A.C., et al. Embolization itself stimulates thrombus propagation in pulmonary embolism. Am J Physiol Heart Circ Physiol 2004, 287:H818-H822.